What I liked in the quarterly cash flow and activity report
*AstraZeneca/Starpharma confirmed its Phase 1 clinical trial AZD0466 DEP® is going fall steam ahead and the opening of addittonal sites in the USA is on schedule
*Fleurstat BVgel now ranks as the #1 topical BV treatment in Australia. Metronidazole and Clindamycin both come in topical applications (Metronidazole 0.75% gel 5g, intravaginally Clindamycin 2% vaginal cream 5g)
*Dep Docetaxel, Dep Cabazitaxel, and Dep Irinotecan trials are progressing very well with further efficacy signals in all three trials
*Starpharma is currently finalising arrangements with potential partners prior to commencement of new Targeted (ADC) and non-ADC DEP® programs, following successful meetings at the JP Morgan Healthcare Conference in San Francisco in January.
*Higher priority focusing on antiviral products (SPL 7013 viral conjunctivitis solution)
*Starpharma’s business operations continue to operate with minimal disruption
*The design of the DEP® clinical programs is such that COVID-19 is not expected to adversely affect the integrity of trial results.
*Currently there has been no disruption with supply of VivaGel® BV to end users. The supply chain activities and key inventory levels remain adequate.
*Estimated quarters of funding available........43 (this is 10 + years worth of funds)!!!
- Forums
- ASX - By Stock
- 46 Quarters of funding available means no further capital raisings for a decade
What I liked in the quarterly cash flow and activity report...
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.90M |
Open | High | Low | Value | Volume |
9.9¢ | 10.5¢ | 9.8¢ | $13.05K | 130.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46828 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 2998 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 46828 | 0.098 |
4 | 865495 | 0.097 |
1 | 50000 | 0.096 |
3 | 176316 | 0.095 |
3 | 150000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 2998 | 1 |
0.100 | 69981 | 3 |
0.105 | 56878 | 2 |
0.110 | 210058 | 7 |
0.115 | 122327 | 4 |
Last trade - 13.20pm 18/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |